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Abstract objective To explore the chronic disease services in Uganda: their level of utilisation, the total
service costs and unit costs per visit.
methods Full financial and economic cost data were collected from 12 facilities in two districts,
from the provider’s perspective. A combination of ingredients-based and step-down allocation costing
approaches was used. The diseases under study were diabetes, hypertension, chronic obstructive
pulmonary disease (COPD), epilepsy and HIV infection. Data were collected through a review of
facility records, direct observation and structured interviews with health workers.
results Provision of chronic care services was concentrated at higher-level facilities. Excluding
drugs, the total costs for NCD care fell below 2% of total facility costs. Unit costs per visit varied
widely, both across different levels of the health system, and between facilities of the same level. This
variability was driven by differences in clinical and drug prescribing practices.
conclusion Most patients reported directly to higher-level facilities, bypassing nearby peripheral
facilities. NCD services in Uganda are underfunded particularly at peripheral facilities. There is a
need to estimate the budget impact of improving NCD care and to standardise treatment guidelines.
keywords non-communicable diseases, human immunodeficiency virus, cost, low- and middle-
income countries, Uganda, health systems
Introduction
The prevalence of non-communicable disease (NCD) has
been rising in low- and middle-income countries (LMIC)
over the past years and is likely to increase further [1, 2].
A survey performed in 23 LMIC found that NCDs
(mainly diabetes, cardiovascular diseases, cancers and
chronic respiratory diseases) were responsible for 50% of
the total disease burden in 2005 [3]. According to the
Global Burden of Disease Study 2010, although commu-
nicable, maternal, neonatal and nutritional diseases rank
highest in causes of premature mortality in eastern sub-
Saharan Africa, the percentage of deaths due to these
health problems generally declined, while the percentage
due to NCDs substantially increased between 1990 and
2010 [4]. Many LMICs are therefore now facing a ‘dou-
ble burden’ due to the increasing levels of NCDs and
continuing occurrence of infectious diseases including
HIV infection, which is now a chronic disease (CD) [5].
The WHO Kampala Declaration and Agenda for Global
Action of 2008 (‘health workers for all and all for health
workers’) [6] emphasises the dilemma of this double bur-
den, and the pressure it places on health systems and the
limited resources available to fund them[7].
However, despite this growing pressure, there remains
little understanding about how chronic care services are
and should be provided in LMIC, particularly at the
peripheral health system level. While there has been pro-
gress in disease-specific chronic care programs targeted at
people with human immunodeficiency virus (HIV) infec-
tion, NCDs have not yet seen structured care pro-
grammes in LMIC [8]. This lack of a programmatic
approach exists despite the fact that NCDs and HIV
infection require similar responses from the health sys-
tem: a regular long-term follow-up of patients and an
uninterrupted provision of medicines. Furthermore, many
countries are concerned about healthcare expenditures
associated with NCDs and how best to provide services
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within their scarce resources to meet the growing added
demand for chronic services [9]. In particular, policymak-
ers need country-specific financial information on the
costs of care for NCDs, to plan, budget and assess the
cost-effectiveness of any expansion in NCD service deliv-
ery. However, most available evidence on the current
economic burden on the health system for providing
health services for these diseases is from high-income set-
tings and these are not transferable to LMICs [10]; there-
fore, appropriate data on the costs of NCDs in LMICs
remain extremely scarce.
The objective of this study was to present data on cur-
rent service utilisation and the total and unit (average per
service) costs observed for chronic care from twelve
health facilities of different levels in Uganda aiming to
provide useful information for the country’s emerging
NCD control programme. As Uganda has a well-devel-
oped HIV treatment programme for many years, and
HIV is now seen as a chronic condition, we included data
on HIV care to help estimate the costs of comprehensive
service from chronic conditions. The study was con-
ducted as part of various preparations for a randomised
controlled trial to investigate the feasibility and cost-
effectiveness of interventions to strengthen the health sys-
tems’ response to chronic diseases, to be conducted in
collaboration between local research institutions and
Ministries of Health in Uganda and Tanzania.
Methods
Study setting
The study was carried out in 2012 with the aim of estab-
lishing the availability, utilisation and costs of NCD and
HIV care services, at 12 purposefully selected health facil-
ities in Mpigi and Wakiso districts in southern Uganda,
areas with both rural and urban populations. The dis-
eases considered were diabetes, hypertension, epilepsy,
chronic obstructive pulmonary disease (COPD) and
asthma, and HIV infection.
The health facility types selected included one general
hospital, one health centre level IV (HC IV), seven health
centres level III (HCs III) and three health centres level II
(HCs II). Two HCs III and one HC II were private not
for profit (PNFP), while the others were public govern-
ment-funded HCs. Every Parish is supposed to have an
HC II serving a few thousand people. This is led by an
enrolled nurse and will treat common illnesses and may
have antenatal services. Every subcounty, with a popula-
tion of around ten thousand people, should have an HC
III led by a clinical officer. HCs III have an outpatients
department (OPD), a maternity unit, a functioning
laboratory and may have a small inpatients department.
An HC IV serves a county with a population of around
100 000. In addition to the services available at HCs III,
it commonly has an inpatients department with male,
female and paediatric wards and a theatre for emergency
operations. HCs IV are led by medical officers.
Data collection
All cost data were collected from March 2012 to January
2013. We retrospectively collected full financial and eco-
nomic costs for the calendar year 2011, as the last full
year of audited financial data available at the time. We
adopted the provider perspective, considering all costs
regardless of who paid or funded them. Costs were
obtained for all outpatient services within the health
facility and then apportioned and analysed with a focus
on the diseases under study. We assessed COPD together
with asthma because in clinical practice, they were rarely
distinguished. A combined ‘bottom-up’ ingredients
approach for disease-specific costs and step-down cost
allocation method for overhead costs was used in the
costing [11].
Data on quantities or resource use and prices for each
CD were collected through a review of facility records,
interviews and observation of service utilisation and
entered into structured cost data sheets. In preparation,
to understand the service delivery system for CDs, semi-
structured interviews were carried out among key health
facility personnel. The interviews included questions on
the services available and how they are provided and or-
ganised, human resource availability, facility organogram
and staff time allocated to different departments, supervi-
sion structures, drugs and other supplies distributed to
each facility and the occurrence of stock-outs, referral
systems, and the organisation of specialised clinics for
diabetes, epilepsy and HIV infection that were held at
some facilities. Prior to interviews, observations and data
collection, written informed consent was obtained from
heads of facilities and other health workers using an
information sheet and consent form.
Costs were classified as capital and recurrent costs. For
full details on the sources of both quantity and price data
used, see Appendix 1. Capital costs included building
space, equipment and staff training. All capital costs were
annualised at a discount rate of 3% [12]. Building costs
were measured by mapping the facility and assigning the
building space to different service areas using staff inter-
views. Where several services took place in one space, the
space costs were allocated based on the type, amount and
time used to provide each service. The price of building
space was estimated using market prices for rent for
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similar buildings in the same areas. Equipment costs were
assigned to the different cost centres depending on what
the equipment was used for and the percentage of
patients for each service that used the equipment. Equip-
ment prices were sourced from 2011 supplier catalogues.
Staff training costs were assigned depending on the type
of service the training was for. The cost of training per
day was sourced from interviews with training organisa-
tions.
Recurrent costs included drugs and diagnostics, trans-
port, staff time, supplies and utilities. Staff costs included
salaries and allowances such as housing, lunch and uni-
form. Staff costs were allocated to the different disease
costs using the amount of time staff spent working on
those conditions obtained through staff interviews and
observation. Apart from HIV treatment, which has
strictly followed prescription standards, there were no
records found for a complete list of drugs used by condi-
tion for the entire year. To estimate annual drug costs,
we collected detailed drug utilisation data for the previ-
ous month at the time the facility was visited to under-
stand typical drug prescription patterns in each health
facility. Data on drug prescriptions were obtained from
the OPD register, clinic registers for diabetes and epilepsy
and quarterly reports for HIV infection. Drug prices were
obtained from 2011 supplier catalogues. Drugs were only
costed if they were actually prescribed and provided at a
facility; drugs that were prescribed but then purchased by
patients on their own costs were not included.
Transport costs were obtained from facility expendi-
ture records and vehicle and motorcycle log books. Gen-
eral supplies and utilities costs were obtained from
monthly bills and facility expenditure records and allo-
cated to overheads. Laboratory costs were excluded in
the analysis due to unavailability of data in many facili-
ties and the fact that many facilities were not equipped
to carry out relevant laboratory tests. It should be noted
that this is an omission, and in some instances due to
stock-out of testing reagents, the government health facil-
ities would independently organise to purchase reagents
and continue providing diagnostic services; however,
patients had to pay out of pocket. This was particularly
the case for diabetes.
Data analysis
To assign overhead and support costs to cost centres, we
attached the costs to specific departments; these included
support services (pharmacy and laboratory), overhead
(administration, maintenance and laundry and cleaning)
and medical care services (the diseases being studied). We
assigned a portion of support and overhead service costs
to final diagnosis-related cost centres using step-down
accounting methods [13] based on staff numbers for
administrative costs or use of physical space for mainte-
nance, laundry and cleaning.
To estimate unit costs per visit for each disease from
total costs, data for the total monthly outpatient visits
were obtained from the monthly and quarterly Health
Management Information System (HMIS) reports. This
included an assessment of the number of patients with
CD covered each month and the diagnosis and treatment
they received.
Although chronic care costs are often estimated per
person-year of treatment [14–16], we were not able to
estimate yearly or episode costs because with the excep-
tion of HIV care at larger facilities there was little conti-
nuity of care; and medical records were not available for
a cohort of patients that was followed up continuously
for long periods.
Data were analysed in Microsoft Excel. All costs were
collected in Ugandan shillings and then presented in 2012
United States dollars (USD). The average 2012 exchange
rate of 2582.57 Uganda shillings to 1 USD was used
[17].
Results
Service organisation and availability
Table 1 describes the services provided at each level of
the health system in 2011. Generally, CD services were
more available at higher-level health facilities. Inpatient
services were mainly available at the hospital and HC IV.
Some speciality drugs (e.g. some diabetes and antihyper-
tensive drugs) were only distributed to HCs IV and hospi-
tals; these drugs were therefore only accessible to patients
at higher levels of the health system. Drug prescription
patterns varied between facilities, even at the same level.
Apart from HIV infection for which drug refills were pro-
vided monthly, the periods for which a patient was given
drugs without review lasted 3–4 months at some facilities
and for much shorter periods, a few days or weeks, at
others. Drug refills are free at all government facilities
and are paid for by the patient at private facilities. Many
times government facilities reported drugs stock-outs
especially for diabetes. In such instances, written prescrip-
tions were given to patients who then had to buy the
drugs from a private pharmacy or drug shop. As these
are patient costs, they were not included in the analysis.
While the hospital and HC IV had the minimum number
of the staff required according to staffing norms, only 1
of 7 HCs III and 1 of 3 HCs II had all the staff allocated
to them. Many facilities did not have functional laborato-
© 2015 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 783
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ries and where these existed, they were mainly used for
malaria tests; and equipment needed for other diagnostic
tests was unavailable or not functioning. Some facilities
had weekly or monthly clinics for certain diseases. These
were run by staff with specialised training in the manage-
ment of certain conditions.
Full diabetes services were only available at the hospi-
tal and at PNFP facilities. Services included laboratory
diagnosis and monitoring of blood or urine glucose using
glucometer sticks or urine dipstick tests, regular monitor-
ing of blood pressure and drug refills. The hospital ran a
specialised diabetes clinic twice a week in which lab diag-
nosis, monitoring and drug refills were offered, and
hypertension was treated as a comorbidity. Commonly
used diabetic drugs were metformin and glibenclamide.
Insulin was sometimes available although frequent stock-
outs were reported. The HC IV diagnosed diabetes and
then referred patients to the hospital for treatment. Diag-
nosis was usually performed using a urine glucose dip-
stick test. Health workers reported frequent and long-
lasting stock-outs of dipsticks and in such instances
patients had to pay for them after improvisations were
made by the facilities to independently purchase them.
Smaller facilities did not provide diabetes care but occa-
sionally provided symptomatic treatment if needed. They
usually referred patients to higher facilities. Sometimes
patients were given a prescription for diabetes drugs by
the clinicians and asked to buy the drugs at private phar-
macies and drug shops.
Hypertension services were available at all levels except
at 1 of the 2 government HCs II and were provided by
the OPD. Services available included diagnosis and moni-
toring using a blood pressure machine and drug refills;
however, blood pressure machines used for diagnosis
were not available at 2 of 3 HCs II and 1 of 7 HCs III.
In these cases, patients were sometimes asked to have
their blood pressure taken at a private facility and results
returned. The hypertensive drugs commonly prescribed at
lower-level facilities were propranolol, furosemide and
nifedipine, while higher-level facilities additionally pre-
scribed methyldopa, losartan, bendroflumethiazide, ateno-
lol and captopril.
Care for patients with COPD/asthma comprised clini-
cal diagnosis and drug refills and was available at all lev-
els of the healthcare system and provided through general
OPD services. Officers in charge of health facilities men-
tioned that COPD is usually not distinguished from
asthma and is reported as ‘asthma’ in OPD registers at
all facilities including the hospital. COPD is also not
included on the HMIS report forms. We therefore col-
lected data on ‘asthma’ in adults; however, this included
both cases of asthma and COPD. COPD/asthma servicesT
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available were clinical diagnosis and drug refills and both
conditions were generally treated in OPDs. The most
commonly prescribed drugs were prednisolone, salbuta-
mol and aminophylline.
Epilepsy services were based on clinical diagnosis and
included monitoring and drug refills. The hospital ran a
weekly specialised epilepsy clinic under the mental health
unit, staffed with full-time psychiatry nurses, and usually
monthly inpatient services were also available. The HC
IV provided care for epileptic patients as part of general
OPD services but also had a resident psychiatric nurse. 2
of 7 HCs III operated regular monthly epilepsy clinics
run by a visiting psychiatry specialist from the mental
health department of the district health office, while oth-
ers did this as part of general OPD care and usually only
provided drug refills. None of the HCs II included in this
study offered services for epileptic patients. Common
drugs prescribed for epilepsy were phenobarbital,
phenytoin and carbamazepine.
HIV services were provided as HIV care without anti-
retroviral therapy (ART) for patients on cotrimoxazole
only, or HIV care with ART provision. HIV care was
available at all HCs III, HC IV and the hospital, while
ART services were only available at the hospital, HC IV
and 3 of 7 HCs III. At HCs II, HIV infection was sus-
pected based on clinical diagnosis and referrals made. 2
of 3 HCs II gave patients cotrimoxazole refills.
Table 2 shows the mean number of outpatient visits
per year by each facility level. Generally, higher-level
health facilities received more patients with chronic dis-
ease than lower-level facilities. HIV-related services regis-
tered the highest number of visits even at lower-level
health facilities. The largest number of visits for HIV
care, 10 398, was recorded at the HC IV, which included
Table 2 Annual number of OPD visits and total annual cost by disease and facility level (2012)
Type of service Health facility
Mean annual visits
Mean total service cost
(USD 2012) % Cost for each mean cost type
Mean Range Mean Range
Drugs
(%)
Staff
(%)
Capital
(%)
Other
(%)
NCD
Services
COPD/Asthma Hospital 511 847 2 40 52 6
HC IV 63 128 4 52 42 2
HC III 35 12–66 74.98 44–114 25 55 17 3
HC II 21 13–29 42 29–59 26 51 20 3
Diabetes Hospital 3632 8002 5 54 36 5
HC IV 6 22 15 38 45 2
HC III 34 0–62 123 0–459 25 46 27 2
HC II N/P N/P N/P N/P N/P N/P N/P N/P
Epilepsy Hospital 1368 6698 42 16 38 4
HC IV 284 510 21 30 47 2
HC III 27 0–62 147 0–519 20 52 25 3
HC II N/P N/P N/P N/P N/P N/P N/P N/P
Hypertension Hospital 1219 5668 53 14 30 3
HC IV 245 730 34 36 29 1
HC III 117 11–349 351 44–1218 27 45 25 3
HC II 31 0–32 68 0–117 12 42 43 3
HIV
Services
HCT Hospital 5296 13124 – 5 56 39
HC IV 4983 10017 – 17 39 44
HC III 746 381–1892 2893 563–6287 – 48 26 26
HC II 7 0–7 8 0–17 – 62 12 26
HIV Care/ART Hospital 4529 79345 64 13 22 1
HC IV 10398 164279 49 7 42 2
HC III 3673 3325–4020 32378 31799–32959 41 30 27 2
HC II N/P N/P N/P N/P N/P N/P N/P N/P
HIV Care only HC III 1093 63–1081 11753 1003–22512 4 61 31 4
HC II 31 24–36 68 59–85 30 50 18 2
Hospital (n = 1), HC IV (n = 1), HC III (n = 7), HC II (n = 3).
HCT, HIV counselling and testing; N/P, Service not provided;
HIV care only are patients not yet initiated on ART.
Other includes transport, utilities and general facility supplies including sundries and stationary.
© 2015 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 785
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visits received at outreach clinics, especially in communi-
ties where HIV services were not offered at lower-level
facilities.
Patient visits due to hypertension were recorded at all
levels of health facilities, particularly at the hospital.
Almost all visits due to diabetes occurred at the hospital
and very few at other facility levels. The few diabetes
patient visits at the HC III level were recorded at private
facilities. For epilepsy, 1368 patient visits were registered
at the hospital’s regular clinic and 284 visits at the HC
IV. However, the numbers of epilepsy visits recorded at
HCs III was very low, only 27, despite the fact that these
facilities offered monthly epilepsy clinics.
Total costs
Table 2 also shows the mean total costs by disease for
each level of health facility. The disease service area that
had the highest cost burden was HIV, with NCDs only
incurring a very small fraction of the costs. At the hospi-
tal, HC IV and HCs III, the annual total costs for HIV
services are higher than the combined total cost of the
NCD services. Among the NCD services, COPD/asthma
had the least total cost burden. Across the different levels
of facilities, for all diseases, the hospital and HC IV had
very high total costs compared to lower-level facilities,
with the hospital bearing almost all the cost burden for
diabetes.
The balance across inputs varied. While costs for HIV
care were mainly driven by drug costs, accounting for
64% and 49% of total costs at the hospital and HC IV,
respectively, those for other NCDs were primarily driven
by capital and staff costs.
Figure 1 shows the percentage of total facility costs,
excluding drug costs, spent on HIV care, NCD care and
all other OPD services and the corresponding percentage
of visits made by patients for each disease, at the differ-
ent levels of health services. We excluded drug costs to
provide an indication on the health system burden (in
terms of fixed costs such as capital and human resources)
of different disease groups relative to service utilisation.
Costs for HIV care and other CDs together amounted to
approximately 20%, 75%, 47% and 5% of total non-
drug-related OPD costs at hospital, HC IV, HC III and
HC II levels, respectively. The majority of this was for
HIV care. The total costs for NCD care were below 2%
of total OPD costs at all health facilities. At HC IV and
the hospital, the burden of NCDs in terms of visits is
much higher than their percentage cost allocation. At the
HC III and II, where little or no NCD services are pro-
vided, the cost allocation is a little higher than the bur-
den.
Unit costs
Table 3 presents unit costs per visit for each facility. Unit
costs for HIV services, particularly HIV care with ART,
were much higher than those for NCD services. Unit
costs for HIV/ART services ranged from USD 8.91 to
USD 17.52, and were driven primarily by higher drug
Costs Visits Costs Visits Costs Visits Costs Visits
Hospital HC IV HC III HC II
HIV 18.4% 8.8% 73.8% 20.5% 44.6% 1.7% 3.5% 1.7%
NCDs 1.9% 5.7% 0.2% 0.8% 2.0% 0.9% 1.7% 0.9%
Other OPD
Services 79.7% 85.5% 25.9% 78.7% 53.4% 97.3% 94.9% 96.0%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Figure 1 Total outpatient HIV and NCD
costs and visits as a percentage of facility
outpatient costs and visits.
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and capital costs. Unit costs for NCD services were all
under USD 7 per visit; and there were no substantial dif-
ferences between them.
Across the different levels of facilities, mean unit costs
for COPD/asthma were similar, approximately USD 2
per visit at all facilities, while those for diabetes and epi-
lepsy were up to three times higher at HCs III than at the
HC IV and hospital. The highest unit cost for hyperten-
sion was also observed at HCs III. Some HCs III were
able to provide services at the same costs as HC IV and
hospitals. The pattern in cost variability across facility
levels was primarily driven by salaries, which were
approximately USD 3 per visit at HC III but only around
USD 1 at HCs IV and the hospital. It was also driven by
different levels of drug costs.
The unit costs for PNFP facilities were higher than
those of public government facilities. This was seen in
the unit costs of diabetes, which was USD 2.2 at the hos-
Table 3 Non-Communicable disease and HIV Services unit costs per visit (2012 USD)
Hospital (n = 1) HC IV (n = 1)
HC III (n = 7) HC II (n = 3)
Unit cost per visit Unit cost per visit
Unit cost per visit Unit cost per visit
Mean Range Mean Range
NCD services
COPD/Asthma 1.66 2.04 2.36 1.49–3.70 2.10 1.47–2.77
Salaries 0.67 1.05 1.31 0.74–2.43 1.17 0.71–1.95
Drugs 0.04 0.08 0.61 0.27–1.34 0.44 0.02–0.69
Capital 0.86 0.87 0.37 0.19–0.77 0.43 0.15–0.68
Other 0.09 0.04 0.06 0.02–0.17 0.06 0.003–0.11
Diabetes 2.20 3.63 6.55 1.44–11.76 N/P
Salaries 1.18 1.40 3.34 0.99–7.15 N/P
Drugs 0.11 0.52 1.20 0.37–3.24 N/P
Capital 0.80 1.65 1.85 0.43–3.94 N/P
Other 0.11 0.05 0.07 0.02–0.3 N/P
Epilepsy 4.90 1.79 6.91 2.33–20.75 N/P
Salaries 0.80 0.54 3.82 0.74–9.90 N/P
Drugs 2.06 0.38 1.17 0.33–1.75 N/P
Capital 1.87 0.84 1.73 0.25–8.32 N/P
Other 0.17 0.04 0.16 0.02–0.79 N/P
Hypertension 4.65 2.98 3.50 1.59–6.59 3.29 2.69–3.89
Salaries 0.67 1.05 1.32 0.74–2.47 1.40 0.84–1.95
Drugs 2.49 1.02 0.48 0.99–1.27 0.38 0.32–0.44
Capital 1.37 0.87 1.64 0.50–5.46 1.43 1.35–1.51
Other 0.12 0.04 0.06 0.07–0.11 0.06 0.02–0.17
HIV services
HCT 2.48 2.01 4.11 1.48–7.69 2.41 2.41
Salaries 0.12 0.35 1.99 0.42–4.94 1.10 1.10
Drugs – – – – – –
Capital 1.39 0.78 1.07 0.16–1.84 0.39 0.39
Other 0.97 0.88 1.05 0.90–1.34 0.31 0.92
HIV Care only 3.65 1.03–6.15 2.30 1.64–3.53
Salaries 2.29 0.53–3.57 1.17 0.71–1.95
Drugs 0.56 0.39–0.78 0.65 0.39–0.78
Capital 0.73 0.09–1.70 0.43 0.15–0.69
Other 0.07 0.00- 0.13 0.06 0.00–0.11
HIV Care and ART 17.52 15.80 8.91 7.91–9.91
Salaries 2.31 1.08 2.76 1.19–4.34
Drugs 11.19 7.71 3.32 0.51–6.13
Capital 3.81 6.75 2.62 0.46–4.79
Other 0.21 0.25 0.2 0.13–0.27
N/P: Service not provided at this level of health facility.
HCT, HIV counselling and testing.
Other includes transport, utilities and general facility supplies including sundries and stationary.
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pital, USD 3.63 at the HC IV and USD 6.55 per visit at
HC III, where only private facilities have diabetes ser-
vices. Private facilities also had higher unit costs for sala-
ries, capital and drugs, which were often paid for by the
patients.
Discussion
Our study found that the provision of chronic care ser-
vices in our area was patchy and primarily concentrated
at higher-level facilities rather than at the periphery, sug-
gesting that the population in the mostly rural catchment
areas of these health facilities remain underserved with
respect to these diseases. HIV and hypertension services
were more widely available than services for other CDs
such as epilepsy and diabetes. The low coverage at the
periphery may be due to the fact that patients with
chronic disease may delay seeking care and therefore may
often need more specialised services. However, it is more
likely reflective of the fact that many lower facilities are
not yet able to diagnose and provide appropriate services
for NCDs. While the problem of a rising disease burden
from NCDs has been recognised in Uganda and else-
where in sub-Saharan Africa [1, 7], our study suggests
that health services at the periphery do not yet reflect this
transition. The costs of NCDs as a proportion of overall
health expenditure were negligible, even at higher levels
of care.
Where chronic services were provided across all levels
of the health system (e.g. for COPD/asthma), there were
still differences in resource allocation across levels, with
larger facilities having higher levels of total costs and
resources, but also receiving proportionally more specia-
lised drugs and equipment. For specialised healthcare ser-
vices, this may be inevitable, but our findings suggest that
standard services for NCDs that could be provided rou-
tinely at smaller health facilities require substantially
more resources to cope with the growing burden.
While differences in resource allocation may be deter-
mined by the types and quality of services on offer, the
unit costs of care for some disease were lower at larger
facilities, which may be explained by the fact that much
higher numbers of patients are seen suggesting possible
economies of scale. This in turn suggests that an increase
in allocation of resources to peripheral health facilities,
should it result in an increased level of provision of ser-
vices, may lead to a similar effect – and reduce the varia-
tion between facilities observed – particularly if ‘fixed’
costs like staff can be used more efficiently.
The high variability in costs between facilities of the
same level was in part driven by differences in drug costs.
We observed the greatest variability in drug cost per visit
for epilepsy, hypertension and COPD/asthma, and yet,
the same supplier with a standard price was used. This
variability occurred because prescriptions differed sub-
stantially between facilities even for the same drug and
for similar conditions. The introduction of standard treat-
ment algorithms and prescription guidelines would prob-
ably be cost saving. In addition, achieving a more reliable
supply of drugs is likely to increase adherence and reduce
clinic workloads and may also have a positive knock-on
effect on other costs and overall efficiency [8].
We also observed that private facilities paid higher sal-
aries to their staff, procured more expensive drugs if
deemed necessary and had better equipment. However,
private facilities charge patients for their services, while
in Uganda healthcare provision in the public sector is in
principle free. In this study, we did not collect data on
health care from the user perspective; and an all-inclusive
comparison of public and PNFP health services was not
possible therefore.
Because our study did not assess the costs of CDs to
individual patients, we also do not know the cost burden
of these diseases on households. However, it is likely that
the current underinvestment in the health system with
respect to NCDs may result in overall economic loss to
households and even the society, particularly if persons
with NCDs need to travel significant distances to receive
care, seek care with delay or not at all. This is aggravated
by the fact that the time and transport costs to access
appropriate care may simply be out of reach for the poor
or those living on subsistence farming who have no suffi-
cient cash income.
Uganda is currently making major efforts to improve
chronic care through its emerging NCD control pro-
gramme. The cost data collected in this study will con-
tribute to planning and to costing the scale-up of NCD
services. The health system investment required to
expand NCD services could be minimised if attention is
focused on how to organise these services cost-effectively.
The successes of HIV and tuberculosis programmes in
Africa are encouraging and could provide good examples
for NCD care, keeping in mind that a successful integra-
tion of services would allow cost-effective use of health-
care resources [8]. This has been documented in other
studies. An example is given by a study from Cameroon
where the integration of hypertension and diabetes ser-
vices was found to be feasible and affordable to patients
[18].
Our study had several limitations. As continuous
NCD services are still the exception, data are scarce
and our ability to observe services in real time was lim-
ited. This may lead to an underestimation of cost, as we
may have been unable to identify and capture all
788 © 2015 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
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resource use. The use of routine data also presented a
substantial challenge, although great care was taken to
validate data through other methods such as staff inter-
views. The cost data collected excluded laboratory costs,
as these were not available for many of the facilities.
We were also unlikely to capture the overall burden on
the health system from NCDs. Some of the complica-
tions of NCDs may be experienced in other depart-
ments, if not recognised as being due to NCDs and this
again may have biased our results to underestimate total
NCD expenditures. Nevertheless, our study remains one
of the few available with empirical cost estimates for
NCD services in a real world context, and we hope is
an important source of cost data for those seeking to
scale up NCDs in LMICs.
Conclusion
Our research suggests that NCD services are still chroni-
cally underfunded, particularly at peripheral health facili-
ties in Uganda, as is the case in many other African
countries that are facing a similar rapidly growing disease
burden from NCDs. Our study emphasises the need to
evaluate current services and estimate the budget impact
of improving or introducing NCD care at lower-level
health facilities. There is a particular need for standardi-
sation of treatment guidelines especially drug prescrip-
tions and for making drugs more widely available and to
strengthen service models that are integrated both within
and between facilities. We expect that the study will con-
tribute to the efforts of the emerging public NCD control
programme in Uganda and elsewhere.
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Appendix 1
Sources of resource costs
Resource Source of information
Capital Staff training Key staff interviews, health facility staff training records, training organisations.
Buildings Building measurements, market rental prices.
Equipment Ingredients approach, market replacement costs from 2011 supplier catalogues.
Recurrent Drugs Ingredients approach, drug prescription data from facility records, 2011 drug price lists from
supplier catalogues.
Transport Vehicle and motorcycle log books, petty cash expenditure records.
Staff time Staff interviews, work duty rosters, staff observations, human resource records, salaries and
allowances obtained from the government salary structure for the financial year 2010/2011.
Supplies Facility records, supplier catalogues.
Utilities Monthly bills for electricity, water, telephone services (where applicable) and security, security
staff salaries and allowances, facility expenditure records.
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